1-2 of 2
Eugenio Bucherini
Close
Sort by
Journal Articles

D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study

Clinical Trials & Observations
Gualtiero Palareti, Daniela Poli, Walter Ageno, Cristina Legnani, Emilia Antonucci, Eugenio Bucherini, Sophie Testa, Oriana Paoletti, Antonio Chistolini, Alessandra Serrao, Ida Martinelli, Paolo Bucciarelli, Anna Falanga, Alberto Tosetto, Luca Sarti, Daniela Mastroiacovo, Benilde Cosmi, Adriana Visonà, Rita Carlotta Santoro, Nello Zanatta, Elvira Grandone, Lorenza Bertù, Vittorio Pengo, Lucia Caiano, Paolo Prandoni
Journal: Blood Advances
Blood Adv (2022) 6 (23): 6005–6015.
https://doi.org/10.1182/bloodadvances.2022007973
Published: 2022
Includes: Supplemental data
Journal Articles

Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study

Clinical Trials & Observations
Walter Ageno, Jan Beyer Westendorf, Laura Contino, Eugenio Bucherini, Maria Teresa Sartori, Marco Senzolo, Elvira Grandone, Rita Santoro, Marc Carrier, Aurélien Delluc, Valerio De Stefano, Fulvio Pomero, Marco Paolo Donadini, Alberto Tosetto, Cecilia Becattini, Ida Martinelli, Barbara Nardo, Laurent Bertoletti, Marcello Di Nisio, Alejandro Lazo-Langner, Alessandro Schenone, Nicoletta Riva
Journal: Blood Advances
Blood Adv (2022) 6 (12): 3569–3578.
https://doi.org/10.1182/bloodadvances.2022007397
Published: 2022
Includes: Supplemental data